A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions.
Patients who required coronary artery bypass grafting (CABG) surgery had worse outcomes when they were living with myasthenia gravis (MG), according to a new study published in BMC Anesthesiology. 1 ...
In the final part of his interview with The American Journal of Managed Care®, Jordan Karlitz, MD, of Exact Sciences, discussed clinical-, behavioral-, and policy-based interventions he believes could ...
Ameet Patel, MD, explains how multiple myeloma treatment settings depend on safety, logistics, and patient needs.
Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...
The FDA has approved a new, simplified monthly subcutaneous (SC) dosing schedule for amivantamab and hyaluronidase-lpuj (Rybrevant Faspro; Johnson & Johnson) for the treatment of patients with ...
In the commercial market, PBMs must now pass through 100% of rebates and other remuneration to payers and comply with robust new transparency and reporting rules enforced by CMS, which can penalize ...
Experts at a roundtable in Boston, Massachusetts, on November 19, 2025, discussed multidisciplinary strategies for obesity ...
A majority of counties experienced growth in penetration of Medicare value-based approaches: Medicare Shared Savings Program (MSSP) accountable care organizations (ACOs) and Medicare Advantage (MA).
Kohei Shitara, MD, discusses CLDN18.2-guided therapy, nivolumab plus zolbetuximab, and toxicity management in advanced ...
In an interview with The American Journal of Managed Care®, Levin explained that for patients whose medications are covered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results